ROVIEZZO, FIORENTINA
 Distribuzione geografica
Continente #
NA - Nord America 1.536
EU - Europa 1.158
AS - Asia 538
AF - Africa 24
SA - Sud America 4
Continente sconosciuto - Info sul continente non disponibili 1
Totale 3.261
Nazione #
US - Stati Uniti d'America 1.506
IT - Italia 673
SG - Singapore 245
CN - Cina 182
NL - Olanda 104
IE - Irlanda 90
VN - Vietnam 80
SE - Svezia 75
FI - Finlandia 59
DE - Germania 50
UA - Ucraina 41
CA - Canada 30
GB - Regno Unito 24
CI - Costa d'Avorio 23
FR - Francia 16
IN - India 13
BG - Bulgaria 8
IR - Iran 8
ES - Italia 3
HK - Hong Kong 3
JP - Giappone 3
RS - Serbia 3
BR - Brasile 2
CL - Cile 2
LT - Lituania 2
RU - Federazione Russa 2
SI - Slovenia 2
AT - Austria 1
CH - Svizzera 1
DK - Danimarca 1
EU - Europa 1
KH - Cambogia 1
LU - Lussemburgo 1
MA - Marocco 1
ME - Montenegro 1
NO - Norvegia 1
PH - Filippine 1
PK - Pakistan 1
SA - Arabia Saudita 1
Totale 3.261
Città #
Chandler 314
Singapore 204
Naples 164
Amsterdam 101
Milan 95
Millbury 90
Dong Ket 80
Menlo Park 61
Princeton 61
Napoli 59
Jacksonville 56
Beijing 52
Nanjing 49
Ashburn 44
Woodbridge 42
Boston 41
Des Moines 36
Vallo della Lucania 28
Santa Clara 25
Nanchang 22
Ottawa 22
Wilmington 19
Lawrence 18
Alvignanello 14
Salerno 14
Norwalk 12
Shenyang 11
Caserta 10
Boardman 9
Dublin 8
Jiaxing 8
Sofia 8
Tianjin 8
Hebei 7
Leawood 7
San Mateo 7
Ann Arbor 6
Lappeenranta 6
London 6
Seattle 6
Ardabil 5
Baronissi 5
Changsha 5
Council Bluffs 5
Forlì 5
Krefeld 5
Kronberg 5
Rome 5
Shenzhen 5
Kunming 4
Potenza 4
Anacapri 3
Belgrade 3
Casoria 3
Dearborn 3
Doshin 3
Florence 3
Formia 3
Fort St. James 3
Giugliano In Campania 3
Halle 3
Hong Kong 3
Houston 3
Indiana 3
Minerbio 3
Monmouth Junction 3
Mumbai 3
Orange 3
Padenghe sul Garda 3
San Francisco 3
Southwark 3
Trieste 3
Valdagno 3
Valencia 3
Ariano Irpino 2
Arzano 2
Augusta 2
Brienza 2
Dallas 2
Faenza 2
Falls Church 2
Fisciano 2
Frankfurt am Main 2
Guangzhou 2
Hangzhou 2
Hefei 2
Livorno 2
Los Angeles 2
Lucca 2
Marcianise 2
Marsala 2
Montréal 2
Mugnano di Napoli 2
New Delhi 2
Piana 2
Pianore 2
Pianura 2
Portici 2
Pune 2
Redwood City 2
Totale 2.004
Nome #
Beneficial Effects of Astragalus membranaceus (Fisch.) Bunge Extract in Controlling Inflammatory Response and Preventing Asthma Features 129
MONTELUKAST ESTERS AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME 101
Endothelial nitric oxide synthase activation is critical for vascular leakage during acute inflammation in vivo 91
Protease-activated receptor-2 (PAR2) in cardiovascular system. 79
Development of 1,2,3-Triazole-Based Sphingosine Kinase Inhibitors and Their Evaluation as Antiproliferative Agents 74
Antagonizing S1P3 receptor with cell-penetrating pepducins in skeletal muscle fibrosis 68
17-beta-oestradiol-induced vasorelaxation in vitro is mediated by eNOS through hsp90 and akt/pkb dependent mechanism. 65
Synthesis of Arylpiperazine Derivatives as Protease Activated Receptor 1 Antagonists and Their Evaluation as Antiproliferative Agents 64
Peripheral relaxant activity of apomorphine and of a D1 selective receptor agonist on human corpus cavernosum strips 63
Leukotriene-mediated sex dimorphism in murine asthma-like features during allergen sensitization 60
BUDESONIDE 21-PHOSPHATE SALTS AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME 60
Palmitoylethanolamide Supplementation during Sensitization Prevents Airway Allergic Symptoms in the Mouse 58
Salvinorin A Inhibits Airway Hyperreactivity Induced by Ovalbumin Sensitization 57
Role of adiponectin in sphingosine-1-phosphate induced airway hyperresponsiveness and inflammation 56
Evidence that hydrogen sulfide exerts antinociceptive effects in the gastrointestinal tract by activating KATP channels. 54
Antagonizing S1P3 receptor with Cell-Penetrating Pepducins in Skeletal Muscle Fibrosis 51
Proteinase-activated receptor-2 mediates arterial vasodilation in diabetes. 50
Activation of protease-activated receptor-2 reduces airways inflammation in experimental allergic asthma 49
Human eosinophil chemotaxis and selective in vivo recruitment by sphingosine 1-phosphate 49
Carrageenan-induced mouse paw oedema is biphasic, age-weight dependent and displays differential nitric oxide cyclooxygenase-2 expression 47
Optimization of benzoquinone and hydroquinone derivatives as potent inhibitors of human 5-lipoxygenase 47
Sitagliptin reduces inflammation, fibrosis and preserves diastolic function in a rat model of heart failure with preserved ejection fraction 47
Montelukast salts and pharmaceutical compositions containing the same 46
Protective role of PI3-kinase-Akt-eNOS signalling pathway in intestinal injury associated with splanchnic artery occlusion shock. 45
CROSS TALK BETWEEN TOLL-LIKE RECEPTOR 4 AND PROTEINASE ACTIVATED RECEPTOR 2 IS INVOLVED IN VASCULAR FUNCTION 45
Adiponectin in asthma: Implications for phenotyping 45
5α-dihydrotestosterone abrogates sex bias in asthma like features in the mouse 45
Lack of Ecto-5'-Nucleotidase Protects Sensitized Mice against Allergen Challenge 44
ACE-inhibition ameliorates vascular reactivity and delays diabetes outcome in NODmice. 44
Angiopoietin-2 causes inflammation in vivo by promoting vascular leakage 43
Identification of a pepducin acting as S1P3 receptor antagonist 43
B cell depletion increases sphingosine-1-phosphate-dependent airway inflammation in mice 43
The hallucinogenic diterpene salvinorin A inhibits leukotriene synthesis in experimental models of inflammation 42
Budesonide 21-phosphate sodium salt for use as anti-inflammatory or anti-asthmatic agent. 40
Biosynthesis of H2S is impaired in non-obese diabetic (NOD) mice 40
Synthesis of 2-Methyl-3-indolylacetic Derivatives as Anti-Inflammatory Agents That Inhibit Preferentially Cyclooxygenase 1 without Gastric Damage 40
Beneficial effects of ACE-inhibition with zofenopril on plaque formation and low-density lipoprotein oxidation in watanabe heritable hyperlipidemic rabbits. 40
Toll-like receptor 4 is essential for the expression of sphingosine-1-phosphate-dependent asthma-like disease in mice 40
The 5-lipoxygenase inhibitor RF-22c potently suppresses leukotriene biosynthesis in cellulo and blocks bronchoconstriction and inflammation in vivo 40
Cross-talk between toll-like receptor 4 (TLR4) and proteinase-activated receptor 2 (PAR(2) ) is involved in vascular function 39
Specific gender-related difference in biosynthesis and release of H2S in isolated rat aorta. 38
Diabetic mouse angiopathy is linked to progressive sympathetic receptor deletion coupled to an enhanced caveolin-1 expression. 38
A protective role for proteinase activated receptor 2 in airways of lipopolysaccharide-treated rats 37
CROSS TALK BETWEEN TOLL-LIKE RECEPTOR 4 (TLR4) AND PROTEINASE ACTIVATED RECEPTOR 2 (PAR-2) IS INVOLVED IN VASCULAR FUNCTION 37
Discovery of a benzenesulfonamide-based dual inhibitor of microsomal prostaglandin E2 synthase-1 and 5-lipoxygenase that favorably modulates lipid mediator biosynthesis in inflammation 37
Hydrogen sulphide is involevd in testsosterone vascular effect 35
Hydrogen sulfide inhalation ameliorates allergen induced airway hypereactivity by modulating mast cell activation 35
The inhibition of caspase-1- does not revert particulate matter (PM)-induced lung immunesuppression in mice 35
Essential requirement for sphingosine kinase activity in eNOS-dependent NO release and vasorelaxation 34
Sphingosine-1-phosphate administration in vivo induces airway inflammation and hypereactivity in a IgE-dependent manner 33
S1P-induced airway smooth muscle hyperresponsiveness and lung inflammation in vivo: molecular and cellular mechanisms 33
Discovery and Optimization of Indoline-Based Compounds as Dual 5-LOX/sEH Inhibitors: In Vitro and In Vivo Anti-Inflammatory Characterization 32
Sphingosine-1-phosphate/Sphingosine Kinase Pathway is Involved in Mouse Airway Hyper-responsiveness 32
Involvement of proteinase activated receptor-2 in vascular response to sphingosine-1-phosphate 32
Exploration of Long-Chain Vitamin e Metabolites for the Discovery of a Highly Potent, Orally Effective, and Metabolically Stable 5-LOX Inhibitor that Limits Inflammation 32
HYDROGEN SULPHIDE IS AN ENDOGENOUS INHIBITOR OF PHOSPHODIESTERASE ACTIVITY 31
Endogenous metabolites of vitamin E limit inflammation by targeting 5-lipoxygenase 31
Functional contribution of sphingosine-1-phosphate to airway pathology in cigarette smoke-exposed mice 31
Exacerbation of Allergic Airway Inflammation in Mice Lacking ECTO-5′-Nucleotidase (CD73) 30
Systemic administration of sphingosine-1-phosphate increases bronchial hyperresponsiveness in the mouse. 29
Disodium cromoglycate inhibits asthma-like features induced by sphingosine-1-phosphate 29
Sphingosine-1-phosphate/TGF-β axis drives epithelial mesenchymal transition in asthma-like disease 29
Effects of sex hormones on bronchial reactivity during the menstrual cycle. 28
Hydrogen sulphide is involved in testosterone vascular effect 27
Sphingosine-1-phosphate modulates vascular permeability and cell recruitment inacute inflammation in vivo. 27
Prednisone-hydrogen sulfide releasing hybrid shows improved therapeutic profile in asthma 26
Hydrogen sulfide is an endogenous inhibitor of phosphodiesterase activity 26
Glucocorticoid receptor nitration leads to enhanced anti-inflammatory effects of novel steroid ligands. 25
Tedanol: a potent anti-inflammatory ent-pimarane diterpene from the Caribbean sponge Tedania ignis 25
Nociceptin/Orphanin Fq in inflammation and remodeling of the small airways in experimental model of airway hyperresponsiveness 25
Synthesis and pharmacological evaluation of peptide-mimetic protease-activated receptor-1 antagonists containing novel heterocyclic scaffolds 24
Urotensin II: A Novel Target in Human Corpus Cavernosum 24
A vitamin E long-chain metabolite and the inspired drug candidate α-amplexichromanol relieve asthma features in an experimental model of allergen sensitization 24
In vivo delivery of the caveolin-1 scaffolding domain inhibits nitric oxide synthesis and reduces inflammation. 22
Geldanamycin, an inhibitor of heat shock protein 90 (Hsp90) mediated signal transduction has anti-inflammatory effects and interacts with glucocorticoid receptor in vivo. 21
Enhanced efficacy of formoterol-montelukast salt in relieving asthma features and in preserving β2-agonists rescue therapy 20
Elucidation of the molecular mechanism and the efficacy in vivo of a novel 1,4-benzoquinone that inhibits 5-lipoxygenase 20
Recent advances in the search for novel 5-lipoxygenase inhibitors for the treatment of asthma 19
Editorial: Sex Differences in Inflammatory Diseases 17
Skeletal Muscle Oxidative Metabolism in an Animal Model of Pulmonary Emphysema: Formoterol and Skeletal Muscle Dysfunction. 17
Nociceptin/orphanin FQ receptor activation decreases the airway hyperresponsiveness induced by allergen in sensitized mice 17
Novel series of benzoquinones with high potency against 5-lipoxygenase in human polymorphonuclear leukocytes 16
Caspase-11 and AIM2 inflammasome are involved in smoking-induced COPD and lung adenocarcinoma 15
Proteinase activated receptor-2 counterbalances the vascular effects of endothelin-1 in fibrotic tight-skin mice 15
Montelukast improves symptoms and lung function in asthmatic women compared with men 15
Nociceptin reduces the inflammatory immune microenvironment in a conventional murine model of airway hyperresponsiveness 14
Sphingosine-1-phosphate contributes to TLR9-induced TNF-α release in lung tumor cells 10
null 10
Design, Synthesis, and Pharmacological Characterization of a Potent Soluble Epoxide Hydrolase Inhibitor for the Treatment of Acute Pancreatitis 10
Leukotriene-mediated sex dimorphism in pulmonary arterial hypertensionmonocrotaline-induced rat. 7
Nogo-A reduces ceramide de novo biosynthesis to protect from heart failure 6
Isothiocyanate-Corticosteroid Conjugates against asthma: Unity makes strength 5
Totale 3.470
Categoria #
all - tutte 13.732
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 13.732


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020173 0 0 0 28 30 10 12 2 1 25 40 25
2020/2021334 11 10 34 9 17 50 16 3 26 11 57 90
2021/2022631 11 5 12 99 4 31 2 16 75 54 123 199
2022/2023745 91 51 28 66 95 75 5 81 111 94 39 9
2023/2024730 54 97 108 33 28 29 27 56 29 9 128 132
2024/2025304 128 151 18 7 0 0 0 0 0 0 0 0
Totale 3.470